Skip to main content

Corporate News tagged:

Human tissue testing

REPROCELL Corporate News

On 16 October 2023, Silo Pharma announced positive data for the effects of SPU-21 in inflamed human synovial tissue to inhibit the progression of rheumatoid arthritis (RA). Preclinical data from...

1